Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Xeris Biopharma Holdings, Inc. logo

Xeris Biopharma Holdings, Inc. (XERS) Stock Ticker

NASDAQ: XERS · Healthcare · Biotechnology
$9.10+1.68%
USD · as of 2026-09-28 · market cap $1.6B
Open XERS in TickrDownload for iPhone

XERS right now

Options expect by Oct 6±8.8%
Options expect by Oct 29±18.2%
Priced in for Nov 5 earnings±20.2%
IV rank (30-day)15% · cheap
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full XERS picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on XERS
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings, Inc. operates as a biopharmaceutical company, focusing on the development and commercialization of therapeutic solutions for individuals across the fields of endocrinology, neurology, and gastroenterology. Its current portfolio includes: Gvoke: A ready-to-administer liquid glucagon designed to treat severe hypoglycemia. Keveyis: A therapy addressing hyperkalemic, hypokalemic, and related forms of primary periodic paralysis. Recorlev: A cortisol synthesis inhibitor approved for managing endogenous hypercortisolemia in adult patients with Cushing's syndrome. Beyond its marketed products, the company maintains an active development pipeline. This pipeline seeks to broaden the applications and indications for existing treatments and introduce novel pharmaceuticals leveraging its proprietary XeriSol and XeriJect formulation technology platforms. Founded in 2005, Xeris Biopharma is headquartered in Chicago, Illinois.

XERS stock facts

Ticker symbolXERS
ExchangeNASDAQ Global Select
SectorHealthcare
IndustryBiotechnology
Market cap$1.6B
CEOJohn Shannon
Employees435
HeadquartersChicago, IL, US
IPO date2018-06-21
Websitewww.xerispharma.com

What you can see for XERS on Tickr

Live XERS price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the XERS report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Xeris Biopharma Holdings, Inc.?

The ticker symbol for Xeris Biopharma Holdings, Inc. is XERS, listed on the NASDAQ Global Select.

What is XERS?

Xeris Biopharma Holdings, Inc. operates as a biopharmaceutical company, focusing on the development and commercialization of therapeutic solutions for individuals across the fields of endocrinology, neurology, and gastroenterology. Its current portfolio includes: Gvoke: A ready-to-administer liquid glucagon designed to treat severe hypoglycemia. Keveyis: A therapy addressing hyperkalemic,…

HomeExploreMarketLists
All pages